title: Does the implementation of an interferon-gamma release assay in lieu of a tuberculin skin test increase acceptance of preventive therapy for latent tuberculosis among healthcare workers?
authors.affiliation: Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio 44195, USA. sahnir@ccf.org
authors.forename: Rajiv
authors.initials: R
authors.lastname: Sahni
authors.forename: Cyndee
authors.initials: C
authors.lastname: Miranda
authors.forename: Belinda
authors.initials: B
authors.lastname: Yen-Lieberman
authors.forename: J Walton
authors.initials: JW
authors.lastname: Tomford
authors.forename: Paul
authors.initials: P
authors.lastname: Terpeluk
authors.forename: Pearl
authors.initials: P
authors.lastname: Quartey
authors.forename: Lucileia T
authors.initials: LT
authors.lastname: Johnson
authors.forename: Steven M
authors.initials: SM
authors.lastname: Gordon
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use; D006282:Health Personnel; D006801:Humans; D007371:Interferon-gamma / Q000097:blood*; D007538:Isoniazid / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000276:immunology; D009820:Ohio; D010342:Patient Acceptance of Health Care; D011933:Reagent Kits, Diagnostic / Q000706:statistics & numerical data*; D014374:Tuberculin Test; D014376:Tuberculosis / Q000175:diagnosis / Q000517:prevention & control
chemical_list: D000995:Antitubercular Agents; D011933:Reagent Kits, Diagnostic; D007371:Interferon-gamma; D007538:Isoniazid